LXRX · Company research

Lexicon Pharmaceuticals, Inc. (LXRX): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

18records availableHealthcare

Stock News & Events data

Database-backed records only

18 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
LXRX Apr 2027 1.000 call (LXRX270416C00001000) Interactive Stock Chart - Yahoo! Finance CanadaLXRX Apr 2027 1.000 call (LXRX270416C00001000) Interactive Stock Chart Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 9, 2026neutral00.6
Lexicon Pharmaceuticals (LXRX) Short Interest & Short Float | Updated Oct 2026 $LXRX - MarketBeatLexicon Pharmaceuticals (LXRX) Short Interest & Short Float | Updated Oct 2026 $LXRX MarketBeatView source ↗MarketBeatOct 9, 2026neutral00.6
Lexicon Pharmaceuticals, Inc. - Common Stock (Nasdaq:LXRX) Stock Quote - FinancialContentLexicon Pharmaceuticals, Inc. - Common Stock (Nasdaq:LXRX) Stock Quote FinancialContentView source ↗FinancialContentOct 6, 2026neutral00.6
Lexicon Pharmaceuticals (LXRX) Stock Fair Value Rises After SONATA HCM Trial Progress - Yahoo FinanceLexicon Pharmaceuticals (LXRX) Stock Fair Value Rises After SONATA HCM Trial Progress Yahoo FinanceView source ↗Yahoo FinanceOct 1, 2026neutral00.6
Lexicon Pharmaceuticals (NasdaqCM:LXRX) Stock Forecast & Analyst Predictions - Simply Wall StreetLexicon Pharmaceuticals (NasdaqCM:LXRX) Stock Forecast & Analyst Predictions Simply Wall StreetView source ↗Simply Wall StreetSep 28, 2026neutral00.6
Why Lexicon Pharmaceuticals Stock Popped by Almost 6% Today - Yahoo FinanceWhy Lexicon Pharmaceuticals Stock Popped by Almost 6% Today Yahoo FinanceView source ↗Yahoo FinanceSep 28, 2026neutral00.6
Sotagliflozin Linked to Fewer Heart-Failure Events in Patients With BP as Low as 100 - Stock TitanSotagliflozin Linked to Fewer Heart-Failure Events in Patients With BP as Low as 100 Stock TitanView source ↗Stock TitanAug 31, 2026neutral00.6
LXRX Stock Edges Higher On $10M Payout From Novo Nordisk — Retail Traders Highlight More Cash Milestones On The Horizon - StocktwitsLXRX Stock Edges Higher On $10M Payout From Novo Nordisk — Retail Traders Highlight More Cash Milestones On The Horizon StocktwitsView source ↗StocktwitsAug 24, 2026neutral00.6
Analysts Have Made A Financial Statement On Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Second-Quarter Report - Simply Wall StreetAnalysts Have Made A Financial Statement On Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Second-Quarter Report Simply Wall StreetView source ↗Simply Wall StreetAug 11, 2026neutral00.6
Lexicon Pharmaceuticals (LXRX) Stock Faces Cash Burn As Revenue Dries Up - Simply Wall StreetLexicon Pharmaceuticals (LXRX) Stock Faces Cash Burn As Revenue Dries Up Simply Wall StreetView source ↗Simply Wall StreetAug 8, 2026neutral00.6
$LXRX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative$LXRX stock is down 10% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJun 30, 2026neutral00.6
LXRX Forecast — Price Target — Prediction for 2027 - TradingViewLXRX Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Here's Why You Should Add LXRX Stock to Your Portfolio Now - Yahoo FinanceHere's Why You Should Add LXRX Stock to Your Portfolio Now Yahoo FinanceView source ↗Yahoo FinanceJun 22, 2026neutral00.6
Here's Why You Should Add LXRX Stock to Your Portfolio Now - TradingViewHere's Why You Should Add LXRX Stock to Your Portfolio Now TradingViewView source ↗TradingViewJun 22, 2026neutral00.6
Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now? - Yahoo FinanceIs Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now? Yahoo FinanceView source ↗Yahoo FinanceJun 11, 2026neutral00.6
How The Lexicon Pharmaceuticals (LXRX) Investment Narrative Is Evolving With Quiet Analyst Updates - Yahoo FinanceHow The Lexicon Pharmaceuticals (LXRX) Investment Narrative Is Evolving With Quiet Analyst Updates Yahoo FinanceView source ↗Yahoo FinanceJun 4, 2026neutral00.6
Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX) - Yahoo FinanceCiti Raises its Price Target on Lexicon Pharmaceuticals (LXRX) Yahoo FinanceView source ↗Yahoo FinanceMay 22, 2026neutral00.6
Lexicon targets diabetes filing, heart trial, obesity study milestones - Stock TitanLexicon targets diabetes filing, heart trial, obesity study milestones Stock TitanView source ↗Stock TitanMay 7, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.